Clinical Study

Phase II Randomized Study Of Rituximab, Methotrexate, Procarbazine, Vincristine, And Cytarabine With And Without Low-Dose Whole-Brain Radiotherapy For

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Specialties:
  • Type of Study: Drug

This study is to determine the effects, good and/or bad, of the combination of low-dose whole brain radiation plus chemotherapy compared with chemotherapy alone, on patients and their tumors. The study will last 6-7 months

Criteria:

Eligible Patients Must Have Primary Central Nervous System Lymphoma (Pcnsl)

Keywords:

Brain Tumor, Central Nervous Syst, Lymphoma, Phase Ii, Rtog 1114

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.